# Myfortic, Prograf, and Corticosteroids in de Novo Liver Transplantation

> **NCT01467011** · — · COMPLETED · sponsor: **R. Mark Ghobrial, MD** · enrollment: 25 (actual)

## Conditions studied

- End Stage Liver Disease

## Interventions

- **DRUG:** Enteric-coated Mycophenolate Sodium

## Key facts

- **NCT ID:** NCT01467011
- **Lead sponsor:** R. Mark Ghobrial, MD
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2018-05-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01467011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01467011, "Myfortic, Prograf, and Corticosteroids in de Novo Liver Transplantation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01467011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*